A comparative study of hFIX expression mediated by rAAV8 and rAAV1 administrated intramuscularly

References

• Alisky JM, Hughes SM, Sauter SL, et al. Transduction of murine cerebellar neurons with recombinant FIV and AAV5 vectors. Neuroreport 2000; 11: 2669–73
   PubMed Web of Science ®Google Scholar
• Davidson BL, Stein CS, Heth JA, et al. Recombinant adeno-associated virus type 2, 4, and 5 vectors: transduction of variant cell types and regions in the mammalian central nervous system. Proc Natl Acad Sci USA 2000; 97: 3428–32
   PubMed Web of Science ®Google Scholar
• Rabinowitz JE, Rolling F, Li C, et al. Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity. J Virol 2002; 76: 791–801
   PubMed Web of Science ®Google Scholar
• Xiao W, Chirmule N, Berta SC, et al. Gene therapy vectors based on adeno-associated virus type 1. J Virol 1999; 73: 3994–4003
   PubMed Web of Science ®Google Scholar
• Broekman MLD, Comer LA, Hyman BT, et al. Adeno-associated virus vectors serotyped with AAV8 capsid are more efficient than AAV1 or -2 serotypes for widespread gene delivery to the neonatal mouse brain. Neuroscience 2006; 138: 501–10
   PubMed Web of Science ®Google Scholar
• Klein RL, Dayton RD, Leidenheimer NJ, et al. Efficient neuronal gene transfer with AAV8 leads to neurotoxic levels of tau or green fluorescent proteins. Mol Ther 2006; 13: 517–27
   PubMed Web of Science ®Google Scholar
• Gao GP, Alvira MR, Wang L, et al. Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy. Proc Natl Acad Sci USA 2002; 99: 11854–9
   PubMed Web of Science ®Google Scholar
• Barbon CM, Ziegler RJ, Li C, et al. AAV8-mediated hepatic expression of acid sphingomyelinase corrects the metabolic defect in the visceral organs of a mouse model of Niemann–Pick disease. Mol Ther 2005; 12: 431–40
   Google Scholar
• Wang Z, Zhu T, Qiao CP, et al. Adeno-associated virus serotype 8 efficiently delivers genes to muscle and heart. Nat Biotechnol 2005; 23: 321–8
   PubMed Web of Science ®Google Scholar
• Cao ZW, Li GG, Liang YQ, et al. Study on the expression of coagulation factor mediated by recombinant AAV serotype 8. Prog Biochem Biophys 2007; 34: 80–6
   Google Scholar
• Herzog R, Hagstrom N, Kung S, et al. Stable gene transfer and expression of human FIX following intramuscular injection of recombinant AAV. Proc Natl Acad Sci USA 1997; 94: 5804–9
   PubMed Web of Science ®Google Scholar
• Herzog RW, Yang E, Couto L, et al. Long-term correction of canine hemophilia B by AAV-mediated gene transfer of blood coagulation factor IX. Nat Med 1999; 5: 56–63
   PubMed Web of Science ®Google Scholar
• Michou AI, Santoro L, Christ M, et al. Adenovirus-mediated gene transfer: influence of transgene, mouse strain and type of immune response on persistence of transgene expression. Gene Ther 1997; 4: 473–82
   PubMed Web of Science ®Google Scholar
• Zolotukhin S, Byrne BJ, Mason E, et al. Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield. Gene Ther 1999; 6: 973–85
   PubMed Web of Science ®Google Scholar
• Lin HF, Maeda N, Smithies O, et al. A coagulation factor IX-deficient mouse model for human hemophilia B. Blood 1997; 90: 3962–6
   PubMedGoogle Scholar
• Walter J, You Q, Hagstrom JN, et al. Successful expression of human factor IX following repeat administration of adenoviral vector in mice. Proc Natl Acad Sci USA 1996; 93: 3056–61
   PubMedGoogle Scholar
• Kessler PD, Podsakoff GM, Chen XJ, et al. Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein. Proc Natl Acad Sci USA 1996; 93: 14082–7
   PubMed Web of Science ®Google Scholar
• Svensson EC, Black HB, Dugger DL, et al. Long-term erythropoietin expression in rodents and non-human primates following intramuscular injection of a replication-defective adenoviral vector. Hum Gene Ther 1997; 8: 1797–806
   PubMed Web of Science ®Google Scholar
• Naffakh N, Pinset C, Montarras D, et al. Long-term secretion of therapeutic proteins from genetically modified skeletal muscles. Hum Gene Ther 1996; 7: 11–21
   PubMed Web of Science ®Google Scholar
• Thomas CE, Storm TA, Huang Z, et al. Rapid uncoating of vector genomes is the key to efficient liver transduction with pseudotyped adeno-associated virus vectors. J Virol 2004; 78: 3110–22
   PubMed Web of Science ®Google Scholar
• Nakai H, Fuess S, Storm TA, et al. Unrestricted hepatocyte transduction with adeno-associated virus serotype 8 vectors in mice. J Virol 2005; 79: 214–24
   PubMed Web of Science ®Google Scholar
• Connelly S, Gardner JM, Lyons RM, et al. Sustained expression of therapeutic levels of human factor VIII in mice. Blood 1996; 87: 4671–7
   PubMedGoogle Scholar
• Nathwani AC., Davidoff A, Hanawa H, et al. Factors influencing in vivo transduction by recombinant adeno-associated viral vectors expressing the human factor IX cDNA. Blood 2001; 97: 1258–65
   PubMed Web of Science ®Google Scholar
• Vandenberghe LH, Wang LL, Somanathan S, et al. Heparin binding directs activation of T cells against adeno-associated virus serotype 2 capsid. Nat Med 2006; 12: 967–71
   PubMed Web of Science ®Google Scholar
• Kaplitt MG, Leone P, Samulski RJ, et al. Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain. Nat Genet 1994; 8: 148–54
   PubMed Web of Science ®Google Scholar
• Ali RR, Reichel MB, Thrasher AJ, et al. Gene transfer into the mouse retina mediated by an adeno-associated viral vector. Hum Mol Genet 1996; 5: 591–4
   PubMed Web of Science ®Google Scholar